OxfordOxford Mon - Fri 09:00-17:00 +44(0)1865-600222
OxfordOxford Mon - Fri 09:00-17:00 +44(0)1865-600222
J Venom Res
Aptamers 2019
03-04 April 2019, Oxford
Submit a manuscript


Aptamers 2016 invites demonstration of R&D and laboratory supplies related to DNA/RNA oligonucleotide research and invites commercial sponsorship. You are invited to choose from a variety of highly-competitive sponsorship packages listed below. If your needs are not covered by the offered packages please contact us in the first instance and we shall do our best to develop a package to suit your requirements.

Sponsorship packages

>Gold: Includes a speaker slot AND an exhibition stand
>Silver: Includes a speaker slot OR an exhibition stand
>Refreshment Breaks
>Drinks Reception
>Delegate Bags (max 2)
>Delegate Badges (max 2)
>Symposium Proceedings (max 2)
>Exhibition Stand

For a Booking Form and further information about packages and other promotional opportunities email on:


Terms & Conditions of Booking.

Aptamers 2016 Sponsors

Gold Sponsor and Exhibitor


Aptamer Solutions Ltd is a York based Biotechnology Company specialising in the custom selection of high-affinity and highly specific nucleic acid aptamers for use in the life sciences sector. Our proprietary automated high-throughput aptamer selection processes allow us to offer a flexible and competitive pricing structure for the development of RNA and DNA aptamers. In addition, we are about to launch a new complementary technology in the area of biomarker discovery.

Our proprietary aptamer based biomarker discovery platform and proprietary combinatorial libraries contain up to and over 1018 different molecules, this diversity and bespoke library design is fundamental to the success of the screening process. This technology enables us to greatly speed up the identification of novel biomarkers as well as diagnostics and/or therapeutic candidate molecules. This technology builds on one of the most powerful uses of aptamer technology, which is the ability for aptamers to be isolated against targets without any prior knowledge of the target.

Our aptamer-based proteomic technology identifies novel biomarkers within the cell surface (such as tumours, cell lines or stem cells) or in samples of biological fluids (such as, urine, plasma and saliva). The technology is versatile and can also be applied to viruses, bacteria, fungi or any other cell based materials or extracts. The discovery process is driven by identifying differences between sample population using enormous aptamer libraries. Samples are prepared based on broad classifications such as: disease vs normal; pre-metastatic vs. post metastatic cancers; pathogenic vs non-pathogenic fungi etc. The process is fast and efficient and identifies differences between ‘healthy’ and ‘diseased’ whilst simultaneously developing the affinity reagent. This cuts out many of the steps associated with traditional biomarker discovery processes.

Gold Sponsor and Exhibitor


RIBOMIC Inc is a biopharmaceutical venture company based in Tokyo. The company is developing molecular targeted pharmaceutical drugs using RNA aptamers with its unique and advanced platform technologies called the RiboART System.

RIBOMIC has been promoting the pharmaceutical discovery program in collaboration with Otsuka Pharmaceutical Co., Ltd., Taisho Pharmaceutical Co., Ltd., The University of Tokyo, and some other academic partners. Especially in April 2014, RIBOMIC entered into a world-wide exclusive license agreement for the anti-NGF aptamer (RBM004) with Fujimoto Pharmaceutical Corporation. In September 2015, RIBOMIC Inc. was listed on The Tokyo Stock Exchange Corporation Mothers Market…read more on the company website

Bronze Sponsor and Exhibitor


HORIBA is a Japanese company divided in 5 segments, Automotive test systems, Process and Environment, Medical, Semiconductors and Scientific. The HORIBA Group mission is to provide superior technologies, unique products, and top-quality services in the analytical and measurement fields. Applying core technologies accumulated over the years, HORIBA provides products and services derived from unremitting research and development. Throughout its business activities, the HORIBA Group energetically focuses on three concerns: the environment, safety, and health. HORIBA Scientific is a worldwide leader in development and production of analytical measurement equipment for research, analysis for laboratories, and quality control. Life science is the scientific pursuit of life and its processes. This contributes to improving the Quality of Life and the progress of drug development and medical treatment, and is connected to mankind’s ultimate concern, «living life in good health». Materials and physico-chemical mechanisms play a central role in life phenomena. Thanks to our long-standing expertise in advanced materials, HORIBA Scientific has developed a full range of instruments (Fluorescence and Raman spectroscopy, Particle size analysers, ellipsometry and  Surface Plasmon Resonance Imaging) to improve our understanding of life, from the molecular to the organism level. 

Bronze Sponsor and Exhibitor


Izon Science designs, manufactures and sells precision instrumentation for nano- and micro-scale particle analysis.  Using its technology, Tunable Resistive Pulse Sensing (TRPS), thousands of particles can be accurately analyzed for their size, concentration and charge.  The technology is highly flexible and directly measures a wide range of biological and synthetic particles with individual particle resolution.   Applications include the characterization of extracellular vesicles, viruses, cells and nanoparticles and microbubbles for drug delivery research.  Izon’s instruments are in use in research institutes, universities, and pharmaceutical and biotechnology companies around the world.

Bronze Sponsor and Exhibitor

ATDBioATDBio was established to provide high quality oligonucleotides to scientists around the world. ATDBio oligonucleotides are used successfully in academic and commercial research in the fields of genetics, genomics, molecular biology, biochemistry, biotechnology and nanotechnology. We supply a wide range of custom-made unmodified and chemically modified oligonucleotides for small and large scale applications. ATDBio specialises in highly modified oligonucleotides. Each oligonucleotide we make is unique, and we insist on the highest standards to maintain the best possible quality for every oligonucleotide. 

Bronze Sponsor and Exhibitor


AuramerBio is an aptamer development company from Wellington New Zealand, we specialise in the translation of aptamer science into analytical tools and diagnostic assays. Our team is particularly proficient with small molecule targets, as illustrated by our growing catalogue of gold standard hormone binding aptamers. It is our vision to see aptamer science break out of niche science labs and into mainstream analytical and diagnostic use. As well as offering a number of aptamer based assays we are also developing a quantitative point of care device for measuring fertility hormones. Our team has a wide skill-base consisting of molecular biologists, synthetic chemists, physicists and surface chemistry experts positioning us perfectly to rapidly deploy aptamers into many analytical assay and device platforms.   

We work with a wide range of customers from academic to commercial to develop aptamer solutions to meet their needs. Using our proprietary selection and optimisation methods we can produce industry leading DNA aptamers to bind the target of your choice. Once an aptamer has been developed we also offer a service to optimise the performance of the aptamer on a range of assay platforms.

Please contact us to discuss your aptamer development needs: jeremy.jones@auramerbio.com or chat to us at Aptamers 2016.

Lunch Sponsor


2bind GmbH, Regensburg, Germany, provides biophysical analyses of molecular interactions. We work with worldwide customers from pharma, biotech as well as universities on the characterization of molecular interactions in terms of binding affinities, stoichiometries and binding energetics. Our semi-automated platform based on the MicroScale Thermophoresis technology (MST) allows us to offer cost-efficient, precise and fast analyses of molecular interactions. The integrated quality controls of the MST system enable us to easily identify sticking and aggregation effects and to directly improve measurement conditions ensuring high quality data. In addition to immobilization-free measurements in free solution, MST offers free choice of buffer, allowing close to native measurements in sera and lysates. Besides the low sample consumption our customers benefit from the broad application range of the MST. With our strong expertise in assay development, the company established standardized assays to analyze aptamer-target interactions in semi-high throughput for the aptamer developing industry and scientists. Further MST services includes competition assays, binding site mapping assays and binding assays that simultaneously test multiple binding partners. Hence, our services based on the MST technology are perfectly suitable for the identification, characterization and optimization of aptamer-target interactions.



IBA GmbH – Your partner for custom-made Aptamers

IBA GmbH is a biotech company located in Goettingen, Germany. Since 1991 our nucleic acid division has focused on specialized nucleic acid custom services, which require particular care and highest quality. These include custom-made DNA and RNA oligonucleotides, chimers, modified and labeled nucleic acids (e.g. for real-time PCR) as well as dinucleotides and triphosphates.

Taking advantage of the new Click Chemistry we can offer new dye combination options and unsurpassed labeling densities. More than 200 fluorescent labels and more than 80 modifications are available to suit your needs.

With our expertise in high quality oligonucleotide synthesis we produce custom DNA and RNA Aptamers according to your individual specifications. You ask for it – we synthesize! Just let us know your DNA/RNA sequence and required modification.

For the generation of new DNA or RNA Aptamers we are performing a complete aptamer development process consisting of in vitro selection by SELEX, sequences analysis, aptamer characterization and optimization in collaboration with Fraunhofer Institute for Cell Therapy and Immunology, Branch Bioanalytics and Bioprocesses (IZI-BB), Potsdam.

More details can be found at www.oligo-specialist.com.

Aptamers 2014/15 Sponsors

Gold Sponsor and Exhibitor

AptamerGroup-logoTag-cmyk LinkedIn 

Silver Sponsor